Tailored solutions for complex diseases require systems that replicate patient-specific conditions. Disease modeling and personalized regenerative medicine combine 3D tissue models, patient-derived cells, and bioengineered platforms to predict treatment responses and design targeted therapies. By recreating pathological environments in vitro, researchers can evaluate drug efficacy and explore disease progression mechanisms. This approach reduces dependency on animal models and improves translational relevance. Integration with genomic data, artificial intelligence, and bioprinting allows for highly individualized therapeutic planning. Disease modeling and personalized regenerative medicine enhances precision medicine by aligning cellular behavior with specific genetic and environmental factors, making regenerative interventions more effective and patient-centered.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : AI-integrated high-throughput tissue-chip for brain aging
Kunal Mitra, Florida Tech, United States
Title : Assembly and stability of on-chip microvasculature
Kara E McCloskey, University of California, Merced, United States